Amplification and/or mutation of the epidermal growth factor receptor (EGFR) gene were found in up to 60% of primary GBM cases [8] and are believed to be associated with the development of the malignant phenotype of glioma cells, e.g., proliferation and invasiveness. The gene discussed is EGFR; the disease is glioblastoma.